Document Detail


Antiarrhythmic therapy in atrial fibrillation.
MedLine Citation:
PMID:  20624425     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Currently available antiarrhythmic drugs for the management of AF are not sufficiently effective and are burdened with cardiac and extracardiac side effects that may offset their therapeutic benefits. Better knowledge about the mechanisms underlying generation and maintenance of AF may lead to the discovery of new targets for pharmacological interventions. These could include atrial-selective ion channels (e.g. atrial I(Na), I(Kur) and I(K,ACh)), pathology-selective ion channels (constitutively active I(K,ACh), TRP channels), ischemia-uncoupled gap junctions, proteins related to malfunctioning intracellular Ca2+ homeostasis (e.g., "leaky" ryanodine receptors, overactive Na+, Ca2+ exchanger) or risk factors for arrhythmias ("upstream" therapies). The review will briefly summarize the current pathophysiological and therapeutic concepts of AF. A description of recently developed antiarrhythmic drugs and their proposed pharmacological action will follow. The final section will speculate about some putative targets for antiarrhythmic drug action in the context of the remodelled atria.
Authors:
Ursula Ravens
Related Documents :
17578345 - I(ks) block by hmr 1556 lowers ventricular defibrillation threshold and reverses the re...
7157455 - Direct action of estradiol-17 beta on the atrial action potential.
6979625 - Effect of the calcium antagonists bepridil (cerm-1978) and verapamil on ca++-dependent ...
9715865 - Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachyc...
8139655 - Turning of nerve growth cones induced by neurotransmitters.
14985825 - Cholecystokinin octapeptide inhibits carotid sinus baroreflex in anesthetized rats.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-17
Journal Detail:
Title:  Pharmacology & therapeutics     Volume:  128     ISSN:  1879-016X     ISO Abbreviation:  Pharmacol. Ther.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7905840     Medline TA:  Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  129-45     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Pharmacology und Toxicology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Fetscherstrasse 74, D-01307 Dresden. Ravens@rcs.urz.tu-dresden.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacte...
Next Document:  Visualization of the ischemic core on native human brain slices by potassium staining method.